Quent Capital’s Immunogen Inc IMGN Stock Holding History

Quent Capital’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-187	Closed	-$1K	–	1376
2022 Q3	$1K	Hold	187	–	–	﹤0.01%	1204
2022 Q2	$1K	Hold	187	–	–	﹤0.01%	1151
2022 Q1	$1K	Buy	+187	New	+$1.03K	﹤0.01%	1245

Other funds holding IMGN

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Quent Capital's IMGN Position: Q4 2022 in Review

Quent Capital sold out of Immunogen Inc (IMGN) in Q4 2022, closing a stake of 187 shares — an estimated $1K sold.

Quent Capital first reported a position in IMGN in Q1 2022 and held it in 3 quarters. The position peaked at $1K in Q3 2022. 204 funds tracked by Wall St. Rank hold IMGN as of Q4 2022.

Quent Capital reported no remaining Immunogen Inc position as of Q4 2022 after selling out during the quarter.
Quent Capital sold 187 Immunogen Inc shares in Q4 2022, an estimated $1K.
Quent Capital first reported a position in Immunogen Inc in Q1 2022 and held it in 3 quarters.
Quent Capital's Immunogen Inc position peaked at $1K in Q3 2022.
204 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2022.

Based on Quent Capital's 13F filing for Q4 2022, filed 19 Jan 2023.